These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recovery of cognitive functioning following abstinence from ketamine. Tang WK; Lau CG; Ungvari GS; Lin SK; Lane HY Addict Behav; 2019 Dec; 99():106081. PubMed ID: 31470241 [TBL] [Abstract][Full Text] [Related]
3. Effects of chronic ketamine use on frontal and medial temporal cognition. Chan KW; Lee TM; Siu AM; Wong DP; Kam CM; Tsang SK; Chan CC Addict Behav; 2013 May; 38(5):2128-32. PubMed ID: 23435274 [TBL] [Abstract][Full Text] [Related]
4. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls. Morgan CJ; Muetzelfeldt L; Curran HV Addiction; 2009 Jan; 104(1):77-87. PubMed ID: 19133891 [TBL] [Abstract][Full Text] [Related]
5. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Morgan CJ; Muetzelfeldt L; Curran HV Addiction; 2010 Jan; 105(1):121-33. PubMed ID: 19919593 [TBL] [Abstract][Full Text] [Related]
6. The profile of cognitive impairments in chronic ketamine users. Ke X; Ding Y; Xu K; He H; Wang D; Deng X; Zhang X; Zhou Y; Zhou C; Liu Y; Ning Y; Fan N Psychiatry Res; 2018 Aug; 266():124-131. PubMed ID: 29864611 [TBL] [Abstract][Full Text] [Related]
7. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
8. Relationship between cognitive impairment and depressive symptoms in current ketamine users. Tang WK; Liang HJ; Lau CG; Tang A; Ungvari GS J Stud Alcohol Drugs; 2013 May; 74(3):460-8. PubMed ID: 23490576 [TBL] [Abstract][Full Text] [Related]
9. Other drug use does not impact cognitive impairments in chronic ketamine users. Zhang C; Tang WK; Liang HJ; Ungvari GS; Lin SK Drug Alcohol Depend; 2018 May; 186():1-8. PubMed ID: 29518690 [TBL] [Abstract][Full Text] [Related]
10. Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug. Morgan CJ; Monaghan L; Curran HV Addiction; 2004 Nov; 99(11):1450-61. PubMed ID: 15500598 [TBL] [Abstract][Full Text] [Related]
11. Neuropsychological functioning in young subjects with generalized anxiety disorder with and without pharmacotherapy. Tempesta D; Mazza M; Serroni N; Moschetta FS; Di Giannantonio M; Ferrara M; De Berardis D Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():236-41. PubMed ID: 23796524 [TBL] [Abstract][Full Text] [Related]
13. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders]. Liraud F; Verdoux H Encephale; 2002; 28(2):160-8. PubMed ID: 11972143 [TBL] [Abstract][Full Text] [Related]
14. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug. Fox HC; Parrott AC; Turner JJ J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821 [TBL] [Abstract][Full Text] [Related]
15. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Curran HV; Morgan C Addiction; 2000 Apr; 95(4):575-90. PubMed ID: 10829333 [TBL] [Abstract][Full Text] [Related]
16. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls. Lamers CT; Bechara A; Rizzo M; Ramaekers JG J Psychopharmacol; 2006 Mar; 20(2):302-11. PubMed ID: 16510488 [TBL] [Abstract][Full Text] [Related]
17. In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Curran HV; Monaghan L Addiction; 2001 May; 96(5):749-60. PubMed ID: 11331033 [TBL] [Abstract][Full Text] [Related]
18. Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls. Golding JF; Groome DH; Rycroft N; Denton Z Am J Drug Alcohol Abuse; 2007; 33(2):301-7. PubMed ID: 17497553 [TBL] [Abstract][Full Text] [Related]
19. A prospective study of learning, memory, and executive function in new MDMA users. Wagner D; Becker B; Koester P; Gouzoulis-Mayfrank E; Daumann J Addiction; 2013 Jan; 108(1):136-45. PubMed ID: 22831704 [TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment differs between primary progressive and relapsing-remitting MS. Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]